All Business articles – Page 19
-
-
BusinessLandmark China cancer drug full approval ‘first of a wave’
Chi-Med’s fruquintinib is a result of China’s evolving drug innovation and regulation
-
BusinessBuilding resilience to climate threats
As extreme weather events become more frequent, chemical and pharmaceutical producers are taking steps to fend them off in future
-
BusinessEurope opens gates to CAR-T
First two modified T-Cell cancer therapies approved in the EU, but prices may be prohibitive for public health systems
-
BusinessUS court overturns plant safety rule delay
Appeal finds Trump’s postponement of the 2017 Chemical Disaster Rule was unlawful
-
BusinessUS approves first RNA interference drug
Alnylam’s Onpattro (patisiran) can treat a rare hereditary disease by silencing a specific gene
-
BusinessBusinesses use blockchain to take on trustlessness
Big companies are looking to blockchain technology to track transactions, finds Andy Extance, while upstarts exploit its cryptocurrency origins
-
BusinessUS government ordered to ban chlorpyrifos insecticide
Court gives EPA 60 days to finalise a ban, which was proposed under Obama but reversed by the Trump administration
-
BusinessInnovation in the open
Big companies are partnering with smaller ones – without trying to gobble up all their intellectual property, Anthony King finds
-
BusinessVaccine scandal and heart drug recall show China’s pharma struggles
Fifteen arrests amid evidence of bribery related to vaccines, despite new standards and penalties for fraud
-
BusinessNovartis exit from antibiotics a setback for race against resistance
Experts say business models must change to halt big pharma exodus
-
BusinessTrump coaxes big promises from big pharma
Several drug industry giants are now pledging to freeze price increases in the US, but some suggest the movement is a publicity stunt or worse
-
BusinessDrugmaker blocks Nevada execution
Alvogen obtains a restraining order to delay US prisoner’s execution, saying Nevada state obtained its sedative midazolam via ‘subterfuge’
-
BusinessAmerican chemical industry fights against US tariffs
The Trump administration has imposed an additional 10% tax on 6000 Chinese products, and more than 1500 are related to chemistry
-
-
BusinessJ&J hit with bill for $4.7 billion in damages over talcum powder cancer link
Pharmaceutical and consumer goods giant loses another talc court case to 22 ovarian cancer patients
-
BusinessJ&J and the question of shadow research
Former academic researcher who found that talc is not carcinogenic admits that J&J funded his work, but says that fact is immaterial
-
BusinessGene therapy gathers pace
Sarah Houlton charts the evolution, challenges and opportunities of cell and gene therapy
-
BusinessUbe’s management pays for lax quality checks
Japanese chemical maker announces that ‘quality-related improprieties’ were detected in 24 of its products, including low-density polyethylene
-
BusinessBayer–Monsanto merger momentum
US antitrust regulators approve Bayer’s $66bn takeover of Monsanto, conditional on the company offloading $9bn in assets